18F-FDG PET/CT imaging impacted staging in 40 percent of patients newly diagnosed with esophageal cancer and management in 34 percent of patients, according to a study published online May 11 in the
Journal of Nuclear Medicine. PET/CT may help physicians direct patients to appropriate treatment, which could translate into survival improvements for patients with locally advanced disease.
Contrast-enhanced ultrasound may complement CT angiography surveillance of patients following endovascular repair of abdominal aortic aneurysms (EVAR) and help curb the risk of kidney toxicity, according to a study published online May 15 in
Radiology.
The FDA has cleared ProUroCare ProUroScan elasticity mechanical imaging system, which produces color images of men's prostate glands as an aid in detecting prostate abnormalities that were previously detected by digital rectal exam.
A single complete compression ultrasound study may safely exclude the diagnosis of deep vein thrombosis (DVT) in pregnant and postpartum women, according to a study published in the May issue of
British Medical Journal. However, the authors suggested additional confirmatory data are needed.
The American College of Radiology (ACR) has issued a statement detailing the pros and cons of including breast density information in patient summaries.
General Electric (GE) has reported that its healthcare unit saw a 5 percent increase in revenues and a double-digit increase in earnings in the first quarter of 2012, compared with the first quarter of 2011.
Although research supports ultrasound as the initial imaging tool in the evaluation of pediatric patients with suspected appendicitis, physicians in general emergency departments continued to rely on CT and use of CT grew from 1999 to 2007, according to a study published online April 24 in
Radiology. The findings point to the need for strong appropriateness and imaging use guidelines, the researchers said.
CT and ultrasound imaging do not have a meaningful impact on the negative appendectomy rate for boys older than five years, according to a study published in the May issue of
Pediatrics. The findings led the authors to recommend use of a decision algorithm that incorporates age and gender.
An FDA Advisory Panel voted unanimously April 11 to recommended approval of a new breast cancer screening indication for the somo•v Automated Breast Ultrasound System (ABUS, U-Systems).
Major digital mammography vendors scored well with customers, but concerns about tomosynthesis reimbursement and workflow are prominent, according to the Orem, Utah-based research firm KLAS.
An FDA Advisory Panel is scheduled to decide whether to recommend approval of a new breast cancer screening indication for somo•v Automated Breast Ultrasound (ABUS) System on April 11. If approved by the FDA, somo•v would be approved for use as an adjunct to mammography for women with dense breasts.
The addition of a screening ultrasound or MRI exam to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident breast cancers, according to a study published April 4 in
the Journal of the American Medical Association. The authors noted downsides to both modalities, reinforcing the notion there may be no easy answer to the question of how to best deliver supplemental screening to women with an increased risk of breast cancer.
Patients with gastrointestinal disorders received increasing levels of cumulative radiation exposure from 1999 to 2009, according to a study published in the March issue of
Clinical Gastroenterology and Hepatology. The authors called for the development of evidence-based guidelines for image analysis among this population.
Researchers reported that performing angioplasty is safe—and may be an effective way to treat the venous abnormalities found in those with multiple sclerosis (MS) and provide symptom relief. The findings, which refute a common misconception about the treatment, were presented March 25 at the Society of Interventional Radiology (SIR) scientific meeting in San Francisco.
GE Healthcare and Intel have established an evaluation lab in Israel to jointly test new technologies.
The Pink Lotus Breast Center, a breast center focused on the prevention, screening, diagnosis and treatment of breast cancer, has unveiled GE Healthcare's SenoBright, contrast-enhanced spectral mammography (CESM) technology at its flagship breast center in Beverly Hills, Calif.
Houston Medical Robotics has received FDA 510(k) clearance to market the Euclid Tier 1 Mini Access System, which is a portable, handheld device that integrates ultrasound imaging systems to facilitate placement of a needle and guidewire into a targeted anatomical location for a variety of therapeutics applications.
Siemens Healthcare has released the Acuson S1000 ultrasound system.
Although most of the European women’s health imaging system market will decline over the next five years, overall revenues will increase slightly as a result of growth in the breast imaging system segment, due to the introduction and adoption of more expensive and innovative systems, according to Millennium Research Group.
Ultrasound-based transient elastography provides excellent diagnostic accuracy for detecting cirrhosis due to recurrent infection with hepatitis C virus infection following liver transplantation, according to a study published in the March issue of Liver Transplantation.
